Articles > Devices & Technology

  1. 7 Possible New Ways to Detect Diabetes and Diabetes Complications Early

    By Craig Idlebrook, Glu community manager/GluCraig Voting is now open for the People’s Choice Award, which is part of the T1D Exchange Diabetes Innovation Challenge. The Challenge is a prize competition that seeks to identify the most promising innovations in diabetes care and to award the top innovators with cash and in-kind support. For the […]

    Read More
  1. 5 Possible Artificial Pancreas Ideas for the Future

    You can vote for your favorite new idea for treating diabetes as part of the T1D Exchange Diabetes Innovation Challenge. By Craig Idlebrook, Glu community manager/GluCraig Voting is now open for the People’s Choice Award, which is part of the T1D Exchange Diabetes Innovation Challenge. The Challenge is a prize competition that seeks to identify […]

    Read More
  2. This is How The Glu Community Use CGMs

    We take a look at data from several daily polls to see how people with type 1 diabetes use a CGM, why they choose to use a CGM, and why they don’t. By Colleen Garey, Data Analyst Coordinator at T1D Exchange/GluColleenG In the past year, several new continuous glucose monitors (CGM) have gained FDA approval […]

    Read More
  3. FDA Panel Recommends Approval of Implantable CGM

    If FDA regulators accept the panel’s unanimous decision, then Senseonic’s Eversense would be the first implantable CGM approved for the U.S. market. -by Craig Idlebrook, Glu community and content manager/GluCraig An FDA advisory panel voted 8 to 0 to recommend approval for Senseonic’s Eversense, an implantable continuous glucose monitor (CGM). If FDA regulators accept the […]

    Read More
  1. “Artificial Pancreas” Clinic CEO Indicted

    Trina Health founder G. Ford Gilbert has been accused by the federal government of conspiring with Alabama lawmakers to get insurance coverage for his company’s unproven treatment. -by Craig Idlebrook, Glu community and content manager/GluCraig The owner of a company that touts a controversial “artificial pancreas” in-clinic treatment has been indicted on charges related to […]

    Read More
  2. FDA Approves Dexcom G6, A Fully Integrated CGM

    Compatible insulin pump systems can adjust insulin delivery based on its readings. Big news for CGM users: The FDA announced today that it has approved the Dexcom G6 continuous glucose monitor system (CGM). From the FDA press release, here are 6 facts to know: It’s the first CGM given formal FDA approval to be be […]

    Read More
  3. Medtronic Receives FDA Approval for Standalone Predictive CGM

      The Guardian Connect, a CGM designed for non-pump users, can predict highs and lows from 10 minutes to 60 minutes in advance, according to Medtronic.    In recent years, the type 1 diabetes tech market has become dominated by two companies: Medtronic and Dexcom. Medtronic solidified its hold on the insulin pump market through […]

    Read More
  4. A Sleep Mask to Treat Two Diabetes-Based Eye Conditions

    The treatment, which won an award in the 2016 Diabetes Innovation Challenge, provides a non-surgical treatment option for some people with diabetes with eye issues in the UK.   We’re gearing up for the T1D Exchange 2018 Diabetes Innovation Challenge, a prize competition that seeks to identify the most promising innovations in diabetes care, present […]

    Read More
  5. FreeStyle Libre Will be Covered by Medicare

    Abbott’s device will join the Dexcom G5 as the only continuous glucose monitoring systems covered under the federal program. On January 4th, 2018, Abbott Laboratories announced it had received word that its FreeStyle Libre System will be covered by Medicare. The Centers for Medicare and Medicaid Services (CMS) ruled that the new glucose monitoring system, […]

    Read More
  6. Patients as Partners in Medical R&D

    Medical devices and therapies must go through a series of rigorous clinical trials in order to prove they are safe and effective for patient use. But more and more companies are looking at patient-reported outcomes (PRO) on a larger scale to ensure the solutions they are developing are sustainable, affordable, and accessible for people living […]

    Read More